Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin

BACKGROUND: Zinc-α2-glycoprotein (ZAG) is a novel adipokine that reduces insulin resistance, protecting against type 2 diabetes. However, past studies have been contradictory. This cross-sectional study aims to investigate the association of circulating ZAG with metabolic syndrome (MetS) in middle-a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lei, Lu, Li, Kejia, Li, Ling, Fang, Xia, Zhou, Tingting, Zhang, Cheng, Luo, Yong, Liu, Hua, Li, Xiaoqiang, Zheng, Hongting, Zhang, Lin, Yang, Gangyi, Gao, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556976/
https://www.ncbi.nlm.nih.gov/pubmed/28814962
http://dx.doi.org/10.1186/s12986-017-0210-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556976/
https://www.ncbi.nlm.nih.gov/pubmed/28814962
http://dx.doi.org/10.1186/s12986-017-0210-6

Ejemplares similares